Pazopanib Hydrochloride (HCL): Targeted Cancer Therapy
Prescribed primarily as an anti-cancer drug, pazopanib hydrochloride (HCL) treats renal cell carcinoma and soft tissue sarcoma. Regulated by governments worldwide, the drug is marketed by Novartis and sold under…